オミクロン株対応ワクチンの一部変更承認について|厚生労働省
https://www.mhlw.go.jp/stf/newpage_34956.htmlThe evidence pack includes HTML, screenshots, summaries, and metadata. It can be downloaded on Pro.
オミクロン株対応ワクチンの一部変更承認について|厚生労働省
Open the archived HTML with saved-time metadata attached.
This HTML has CSS and images embedded, so it can still be opened even if the original page disappears.
This page is a press release from the Ministry of Health, Labour and Welfare dated September 1, 2023, announcing partial amendments to three Comirnaty COVID-19 vaccines. The approved vaccines contain mRNA encoding the Omicron XBB.1.5 spike protein. The three variants target different age groups: adults, ages 5-11, and ages 6 months-4 years, with dosages of 0.3mL, 0.2mL, and 0.2mL respectively. All require at least a 3-month interval after previous vaccination. Initial immunization and booster protocols are specified accordingly.
